| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/05/2009 | US7528151 Heterocyclic urea derivatives for the treatment of pain |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | US7528133 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2009055357A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | WO2009055289A2 Therapeutic substituted lactams |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009054468A1 Azolecarboxamide compound or salt thereof |
| 04/30/2009 | WO2009054390A1 Thiazolidinedione compound |
| 04/30/2009 | WO2009053799A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/30/2009 | WO2009053628A2 Novel compounds, preparation and uses thereof |
| 04/30/2009 | WO2009053449A1 Thiazoles which potentiate ampa receptor and medicinal uses thereof |
| 04/30/2009 | WO2009053448A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 04/30/2009 | WO2009033033A3 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases |
| 04/30/2009 | WO2009012482A3 5-membered heterocyclic amides and related compounds |
| 04/30/2009 | WO2008125518A3 Process for the preparation of piperazine benzothiazoles |
| 04/30/2009 | US20090111988 Novel process for production of 5--6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidone) |
| 04/30/2009 | US20090111862 Compound |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111802 Cyclocarbamate derivatives as progesterone receptor modulators |
| 04/30/2009 | US20090111800 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111790 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 04/30/2009 | US20090111789 Chiral cis-imidazolines |
| 04/30/2009 | US20090111151 Production of Polyketides |
| 04/30/2009 | US20090108750 Compound having thiadiazole ring structure substituted with pyridyl group and organic electroluminescent device |
| 04/30/2009 | CA2703653A1 Pyridine and pyrazine derivatives -083 |
| 04/30/2009 | CA2703479A1 Therapeutic substituted lactams |
| 04/30/2009 | CA2703106A1 Azolecarboxamide derivatives as trka inhibitors |
| 04/30/2009 | CA2702772A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | CA2701594A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2051979A2 Polymorphic forms of rosiglitazone base |
| 04/29/2009 | EP2051970A1 Substituted azolin-2-yl-amino compounds |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | EP1542994B1 Novel oxazole compounds as transforming growth factor (tgf) inhibitor |
| 04/29/2009 | EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors |
| 04/29/2009 | CN101421264A Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101421256A Thiadiazolidinone inhibitors of ptpase |
| 04/29/2009 | CN101421255A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/29/2009 | CN100482651C Diaminothiazoles |
| 04/29/2009 | CN100482648C New uracils having a herbicidal activity |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524954 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation |
| 04/28/2009 | US7524876 Luciferin derivatives |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524842 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/28/2009 | US7524837 Benzotriazapinone salts and methods for using same |
| 04/28/2009 | CA2507465C Phenyl substituted piperidine compounds for use as ppar activators |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2227762C Substituted aminouracils |
| 04/23/2009 | WO2009052126A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE |
| 04/23/2009 | WO2009052065A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051796A2 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050523A1 Azetidinyl g-protein coupled receptor agonists |
| 04/23/2009 | WO2009050258A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 04/23/2009 | WO2009050232A1 Cgrp antagonists |
| 04/23/2009 | WO2009049846A1 Insecticidal compounds |
| 04/23/2009 | WO2009049844A1 Insecticidal compounds |
| 04/23/2009 | WO2009049798A1 Iminoheterocycles for insecticides |
| 04/23/2009 | WO2009032558A3 Preparation of ziprasidone hydrochloride monohydrate |
| 04/23/2009 | WO2009024342A3 Novel microbiocides |
| 04/23/2009 | WO2009017822A3 Pi3 kinase modulators and methods of use |
| 04/23/2009 | WO2009012958A3 Tubulysin d analogues |
| 04/23/2009 | WO2009007751A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2009007748A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2008152094A3 Substituted acetamides as modulators of the ep2 receptor |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | WO2005089067A3 Screening of anti-viral drugs and pharmaceutical compositions containing thiazolidinone derivatives |
| 04/23/2009 | US20090105319 Naphthalene-based inhibitors of anti-apoptotic proteins |
| 04/23/2009 | US20090105318 Amidoethylthioether Orexin Receptor Antagonists |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105302 (2-Pyrazol-1-yl-5-trifluoromethylphenyl)carbamic acid 4-cyclopropanesulfonylamino-carbonyl-13-methyl-2,14-dioxo-3,13-diazatricyclo-[13.3.0.04,6]octadec-7-en-17-yl ester; viricides; potency, decreased cytotoxicity, improved pharmacokinetics, improved resistance profile; liver disorders; ritonavir |
| 04/23/2009 | US20090105286 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105255 Glucokinase activators |
| 04/23/2009 | US20090105254 Vhr protein tyrosine phosphatase inhibitors, compositions and methods of use |
| 04/23/2009 | US20090105250 Compounds and compositions as protein kinase inhibitors |
| 04/23/2009 | US20090105248 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 04/23/2009 | US20090105231 Amide derivatives as rock inhibitors |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105209 BTK protein kinase inhibitors |
| 04/23/2009 | US20090104677 Heteroaromatic Selective Inhibitors of Neuronal Nitric Oxide Synthase |
| 04/23/2009 | DE112004001191T5 Aztreonam L-Lysin und Verfahren für dessen Herstellung Aztreonam L-lysine and method for its preparation |